A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Subjects With Hypertension
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Esaxerenone (Primary) ; Eplerenone
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 11 Feb 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 07 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 29 Jan 2015 New trial record